SSGJ-718

N/A

Report date: 2026/04/30 17:46:23

Base Information

Drug NameSSGJ-718

Drug Alias NameSSGJ-718SSGJ718

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Tumor necrosis factor superfamily member 15Anti-Interleukin-23

TargetsTumor necrosis factor superfamily member 15Interleukin-23

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator Companies3sbio Inc

China Registration ClassN/A

Develop Information

Active Companies3sbio Inc

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A